Concepedia

Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

Eva Rosa Petersen, Helle Bach Søndergaard, Julie Laursen, Anna Olsson, Lars Börnsen, Per Soelberg Sørensen, Finn Sellebjerg, Annette Oturai

Multiple Sclerosis Journal · 2018 · 35 citations · 30 references

DOI

Abstract

Smoking intensity was significantly associated with the number of relapses during natalizumab treatment.

References

30

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

W. I. McDonald, Alistair Compston, Gilles Edan et al. · Annals of Neurology · 2001 · 6.9K citations

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer, Sabine Cepok, Jeremy Hobart et al. · Nature · 2011 · 2.7K citations · Full text

, , +15

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

New England Journal of Medicine · 2007 · 1.7K citations

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Christiane Graetz, John Zajicek · Nature Genetics · 2013 · 1.4K citations · Full text

, , +14